Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 1927-1931

  Nikolajsen, Gitte Nykjæ ^a   Jensen, Morten Skovgaard ^a   West, Mark J ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Axons; Fractionator; Space balls; Stereology; VAChT

Indexed keywords

VESICULAR ACETYLCHOLINE TRANSPORTER;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN ATROPHY; BRAIN CORTEX; CELL SIZE; CHOLINERGIC NERVE; CONTROLLED STUDY; FEMALE; MOUSE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THICKNESS;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; AXONS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; MICE;

EID: 80052617736     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.05.006     Document Type: Article

References (24)

1. Boncristiano S., Calhoun M.E., Kelly P.H., Pfeifer M., Bondolfi L., Stalder M., Phinney A.L., Abramowski D., Sturchler-Pierrat C., Enz A., Sommer B., Staufenbiel M., Jucker M. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J. Neurosci 2002, 22:3234-3243.
2. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997, 19:939-945.
3. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 1996, 17:1005-1013.
4. Bronfman F.C., Moechars D., Van Leuven F. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol. Dis 2000, 7:152-168.
5. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
6. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press, Amsterdam. third ed.
7. Freund T.F., Buzsáki G. Interneurons of the hippocampus. Hippocampus 1996, 6:347-470.
8. Iacono D., O'Brien R., Resnick S.M., Zonderman A.B., Pletnikova O., Rudow G., An Y., West M.J., Crain B., Troncoso J.C. Neuronal hypertrophy in asymptomatic Alzheimer disease. J. Neuropathol. Exp. Neurol 2008, 67:578-589.
9. Jankowski J.L., Slunt H.H., Ratovitski T., Jenkens N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS. Biomol. Eng 2001, 17:157-165.
10. Liu Y., Lee M.K., James M.M., Price D.L., Borchelt D.R., Troncoso J.C., Oh E.S. Passive (amyloid-β) immunotherapy attenuates monoaminergic axonal degeneration in the AβPPswe/PS1dE9 mice. J. Alzheimers Dis 2011, 23:271-279.
11. Liu Y., Yoo M.J., Savonenko A., Stirling W., Price D.L., Borchelt D.R., Mamounas L., Lyons W.E., Blue M.E., Lee M.K. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J. Neurosci 2008, 28:13805-13814.
12. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983, 10:1185-1201.
13. Mouton P.R., Gokhale A.M., Ward N.L., West M.J. Stereological length estimation using spherical probes. J. Microsc 2002, 206:54-64.
14. Mufson E.J., Kehr A.D., Wainer B.H., Mesulam M.M. Cortical effects of neurotoxic damage to the nucleus basalis in rats: persistent loss of extrinsic cholinergic input and lack of transsynaptic effect upon the number of somatostatin-containing, cholinesterase-positive, and cholinergic cortical neurons. Brain Res 1987, 417:385-388.
15. Oh E.S., Savonenko A.V., King J.F., Fangmark Tucker S.M., Rudow G.L., Xu G., Borchelt D.R., Troncoso J.C. Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol. Aging 2009, 30:1238-1244.
16. Perez S.E., Dar S., Ikonomovic M.D., DeKosky S.T., Mufson E.J. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Neurobiol. Dis 2007, 28:3-15.
17. Salehi A., Kleshevnikov A., Mobley C. Cholinergic neurodegeneration in Alzheimer's disease. Pharmacological Mechanisms in Alzheimer's Therapeutics 2007, 64-104. Springer, Berlin. A. Claudio-Cuello (Ed.).
18. Savonenko A., Xu G.M., Melnikova T., Morton J.L., Gonzales V., Wong M.P., Price D.L., Tang F., Markowska A.L., Borchelt D.R. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol. Dis 2005, 18:602-617.
19. Slomianka L., West M.J. Estimators of the precision of stereological estimates: an example based on the CA1 pyramidal cell layer of rats. Neuroscience 2005, 136:757-767.
20. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 1998, 8:566-607.
21. Volianskis A., Køstner R., Mølgaard M., Hass S., Jensen M.S. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of β-amyloidosis. Neurobiol. Aging 2010, 31:1173-1187.
22. West M.J., Bach G., Søderman A., Jensen J.L. Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice. Neurobiol. Aging 2009, 30:1756-1776.
23. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol 1981, 10:122-126.
24. Wong T.P., Debeir T., Duff K., Cuello A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci 1999, 19:2706-2716.